Stock Analysis on Net
Stock Analysis on Net

Abbott Laboratories (NYSE:ABT) 

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Abbott Laboratories, common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Short-term borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.27 0.27 0.27
Trade accounts payable 4.39 4.24 4.89 4.90 5.13 5.17 5.15 5.43 5.65 5.77 5.87 5.49 5.74 5.65 6.19 5.68 6.06 6.43 5.86 5.44 5.48 5.59
Salaries, wages and commissions 1.48 1.10 2.01 2.06 1.85 1.43 2.09 2.18 1.90 1.51 2.18 2.05 1.86 1.49 2.09 1.96 1.77 1.55 2.16 1.99 1.70 1.53
Other accrued liabilities 6.31 5.78 6.70 6.98 6.73 6.88 6.32 7.30 6.94 7.20 7.41 7.42 7.27 7.80 7.85 7.52 7.28 7.54 6.89 7.13 7.31 7.21
Dividends payable 1.00 1.00 1.27 1.22 1.23 1.27 1.26 1.29 1.31 1.32 1.30 1.23 1.21 1.20 1.19 1.13 1.11 1.11 1.11 1.08 1.09 1.10
Income taxes payable 0.38 0.54 0.66 0.56 0.46 0.60 0.73 0.96 0.82 0.78 0.67 0.44 0.37 0.45 0.46 0.54 0.48 0.46 0.41 0.50 0.33 0.38
Current portion of long-term debt 2.75 3.99 3.50 1.60 0.60 0.62 1.84 2.90 2.21 2.77 1.48 1.46 3.11 3.10 3.02 1.53 0.01 0.01 1.00 1.02 1.03 1.04
Current liabilities 16.31% 16.64% 19.02% 17.32% 16.00% 15.97% 17.39% 20.04% 18.84% 19.35% 18.90% 18.09% 19.56% 19.69% 20.81% 18.36% 16.70% 17.09% 17.43% 17.44% 17.22% 17.12%
Long-term debt, excluding current portion 27.11 26.84 11.41 13.78 15.39 15.64 15.51 17.25 17.99 17.35 18.57 20.08 19.85 19.81 19.51 21.01 22.58 23.09 23.00 23.64 23.95 24.03
Post-employment obligations, deferred income taxes and other long-term liabilities 9.19 8.80 8.71 8.01 8.10 8.16 8.27 8.88 8.98 9.42 9.49 9.54 9.59 10.05 10.11 11.34 11.24 11.68 11.66 11.98 12.39 12.43
Long-term liabilities 36.29% 35.63% 20.12% 21.78% 23.49% 23.79% 23.77% 26.13% 26.98% 26.77% 28.06% 29.62% 29.45% 29.86% 29.61% 32.35% 33.82% 34.77% 34.67% 35.63% 36.34% 36.46%
Total liabilities 52.61% 52.28% 39.14% 39.10% 39.49% 39.76% 41.16% 46.17% 45.82% 46.12% 46.97% 47.71% 49.01% 49.55% 50.42% 50.71% 50.52% 51.86% 52.09% 53.06% 53.56% 53.58%
Preferred shares, one dollar par value, none issued 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Common shares, without par value, issued at stated capital amount 23.34 22.96 29.44 30.19 30.10 30.85 30.90 33.65 34.04 34.12 33.97 34.30 33.55 33.18 33.19 33.74 32.92 32.84 32.54 32.91 32.96 33.01
Common shares held in treasury, at cost -16.45 -15.34 -19.81 -20.05 -19.77 -20.40 -20.69 -22.16 -21.58 -21.75 -21.83 -21.76 -21.43 -20.74 -20.46 -19.99 -18.49 -18.55 -15.72 -14.90 -14.11 -13.53
Earnings employed in the business 45.59 45.24 57.41 58.33 57.70 58.58 58.05 52.53 52.53 52.45 51.29 51.21 49.56 48.61 47.36 48.23 46.48 44.99 41.93 41.16 39.65 39.39
Accumulated other comprehensive loss -5.69 -5.72 -6.92 -7.94 -7.83 -9.11 -9.71 -10.50 -11.14 -11.27 -10.71 -11.76 -11.00 -10.89 -10.82 -12.97 -11.73 -11.45 -11.14 -12.52 -12.37 -12.76
Total Abbott shareholders’ investment 46.80% 47.14% 60.12% 60.53% 60.20% 59.93% 58.55% 53.52% 53.85% 53.56% 52.73% 51.99% 50.68% 50.15% 49.28% 49.00% 49.18% 47.83% 47.61% 46.65% 46.13% 46.11%
Noncontrolling interests 0.60 0.58 0.74 0.37 0.31 0.31 0.29 0.31 0.33 0.32 0.31 0.30 0.31 0.30 0.29 0.29 0.30 0.31 0.30 0.29 0.31 0.31
Total shareholders’ investment 47.39% 47.72% 60.86% 60.90% 60.51% 60.24% 58.84% 53.83% 54.18% 53.88% 53.03% 52.29% 50.99% 50.45% 49.58% 49.29% 49.48% 48.14% 47.91% 46.94% 46.44% 46.42%
Total liabilities and shareholders’ investment 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).

The financial structure reveals a prolonged period of deleveraging and equity growth from early 2021 through late 2025, followed by a significant shift in the capital composition during the first half of 2026. Total liabilities generally trended downward from 53.58% in March 2021 to a low of 39.10% in September 2025, while total shareholders' investment increased from 46.42% to a peak of 60.90% over the same period.

Liability Composition and Debt Trends
Long-term debt, excluding the current portion, exhibited a consistent decline for the majority of the analyzed period, falling from 24.03% in March 2021 to 11.41% by September 2025. This reduction was mirrored by a decrease in total long-term liabilities, which dropped from 36.46% to 20.12% in the same timeframe. However, a sharp reversal occurred in early 2026, with long-term debt surging to 27.11% by June 2026, indicating a substantial increase in long-term borrowing.
Current liabilities remained relatively stable, fluctuating between 15.97% and 20.81%. Trade accounts payable showed a gradual decline from 5.59% in March 2021 to 4.39% in June 2026. Other accrued liabilities also trended lower, moving from 7.21% to 6.31% over the period.
Equity and Capital Management
Earnings employed in the business served as the primary driver of equity growth, increasing steadily from 39.39% in March 2021 to a peak of 58.33% in September 2025, before correcting to 45.59% in June 2026. This suggests a strong period of retained earnings accumulation.
A consistent program of share repurchases is evident in the common shares held in treasury, which grew from -13.53% in March 2021 to a peak of -22.16% in September 2024, indicating an increasing proportion of capital used to buy back shares. This trend reversed slightly in 2026, returning to -16.45%.
Accumulated other comprehensive loss showed a steady improvement, becoming less negative over time, moving from -12.76% in March 2021 to -5.69% by June 2026.
Structural Shift in 2026
A dramatic pivot in the balance sheet occurred between December 2025 and March 2026. Total liabilities jumped from 39.14% to 52.28%, primarily driven by a spike in long-term debt, which rose from 11.41% to 26.84%. Simultaneously, total shareholders' investment fell from 60.12% to 47.14%. This suggests a strategic shift toward higher leverage, potentially to fund an acquisition or significant capital investment.

AI Ask an analyst for more